Physician

Andrew Thomas Fairchild, MD

According to 2025 Medicare claims, Andrew Fairchild, MD (NPI: 1639524978) practices radiation oncology in the Winston-Salem, NC market, with the plurality of this provider's patient population coming from Forsyth, NC. This provider's primary affiliated billing organization is PIEDMONT RADIATION ONCOLOGY P A (NPI: 1134219108; TIN: 562187873) and primary practice location at 27103-3013.

Fairchild's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 306 traditional Medicare patients, billed 2,410 HCPCS/CPT codes, and received $181,060 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 269 prescription claims across 128 beneficiaries totaling $21,220 in drug costs, led by Tamsulosin Hcl (Tamsulosin Hcl). Open Payments data shows 3 records totaling $1,700. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $4,809 to $21,220. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$91K$181K2021 Medicare payment: $41,091 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $157,501 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $170,923 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $181,060 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202191515$41,091
20222851,870$157,501
20233072,060$170,923
20243062,410$181,060

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$53K$107K2016 Drug cost: $4,809 (USD; Tot_Drug_Cst)2017 Drug cost: $12,672 (USD; Tot_Drug_Cst)2018 Drug cost: $3,639 (USD; Tot_Drug_Cst)2021 Drug cost: $750 (USD; Tot_Drug_Cst)2022 Drug cost: $73,303 (USD; Tot_Drug_Cst)2023 Drug cost: $106,681 (USD; Tot_Drug_Cst)2024 Drug cost: $21,220 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20163998$4,809
201787299$12,672
20183668$3,639
2019N/RN/RN/R
2020N/RN/RN/R
20212640$750
2022126308$73,303
2023153351$106,681
2024128269$21,220

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77427Radiation treatment management, 5 treatment sessions104271$152
77263Complex radiation therapy planning7980$133
77334Design and construction of complex radiation treatment device77121$49
77014Ct guidance for insertion of radiation therapy fields1681,199$36
77300Calculation of radiation therapy dose79201$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Tamsulosin HclTamsulosin Hcl1638,555$1,626

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.3$1,700Myriad Genetic Laboratories, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Andrew Thomas Fairchild, MD?

Tedicare shows public-source Medicare data for Andrew Thomas Fairchild, MD (NPI 1639524978), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Thomas Fairchild, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Andrew Thomas Fairchild, MD?

Andrew Thomas Fairchild, MD is linked to PIEDMONT RADIATION ONCOLOGY P A (billing NPI 1134219108) in the available physician profile data.

Does Andrew Thomas Fairchild, MD have Open Payments data?

Andrew Thomas Fairchild, MD has 3 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.